ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
3
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
5,595
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
News at XI: moving beyond factor Xa inhibitors
Author(s):
James C. Fredenburgh
,
Jeffrey I. Weitz
Publication date
Created:
July 2023
Publication date
(Print):
July 2023
Journal:
Journal of Thrombosis and Haemostasis
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Plant MYBs
Author and article information
Contributors
James C. Fredenburgh:
(View ORCID Profile)
Jeffrey I. Weitz:
(View ORCID Profile)
Journal
Title:
Journal of Thrombosis and Haemostasis
Abbreviated Title:
Journal of Thrombosis and Haemostasis
Publisher:
Elsevier BV
ISSN (Print):
15387836
Publication date Created:
July 2023
Publication date (Print):
July 2023
Volume
: 21
Issue
: 7
Pages
: 1692-1702
Article
DOI:
10.1016/j.jtha.2023.04.021
PubMed ID:
37116752
SO-VID:
2466c9e7-8cb7-41b0-b258-bc6fa18936c8
Copyright ©
© 2023
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
5,595
\(\Xi^-\) and \(\Omega\) Distributions in Hadron-Nucleus Interactions
Authors:
,
Functional characterisation of Vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi
Authors:
Daniella Oliveira
,
Miryam Alvarez-Flores
,
Adriana A. Lopes
…
APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti–Xa reagent used for correlation
Authors:
Pierre Toulon
,
Motalib Smahi
,
Neila De Pooter
See all similar
Cited by
3
Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials
Authors:
John W. Eikelboom
,
Jeffrey I. Weitz
Targeting factor XI and factor XIa to prevent thrombosis
Authors:
David Gailani
,
Andras Gruber
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers
Authors:
Tianxing Liu
,
Kensei Hashizume
,
Eva Krieg
…
See all cited by
Version 1
- Current
Version 1